Concepedia

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy [RETRACTED]

Yoshihiro Satō, Izumi Kondo, Shu Ishida, Hiromichi Motooka, K. Takayama, Yoshihito Tomita, Hajime Maeda, K. Satoh

Neurology · 2001 · 275 citations · 14 references

DOI

Abstract

Long-term VPA monotherapy can increase bone resorption, leading to decreased BMD.

References

14

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Uri Liberman, Stuart Weiss, Johann Bröll et al. · New England Journal of Medicine · 1995 · 2.3K citations

Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>

S. R. Cummings · JAMA · 1998 · 2.3K citations

Effect of carbamazepine and valproate on bone mineral density

Raj D. Sheth, Carl A. Wesolowski, Jayanthi Jacob et al. · The Journal of Pediatrics · 1995 · 295 citations

, , +5

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

M de Silva, B M Macardle, M McGowan et al. · The Lancet · 1996 · 259 citations · Full text

, , +6

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial.

Andrew Heller, Paul Chesterman, Robert Elwes et al. · Journal of Neurology Neurosurgery & Psychiatry · 1995 · 256 citations · Full text

, , +11